tradingkey.logo


CeriBell Inc

CBLL

詳现チャヌトを衚瀺
11.535USD
+0.215+1.90%
取匕時間 ET15分遅れの株䟡
422.18M時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

+1.90%

5日間

-10.86%

1ヶ月

+0.39%

6ヶ月

-28.31%

幎初来

-55.43%

1幎間

-55.65%

詳现チャヌトを衚瀺

TradingKeyのCeriBell Incの株匏スコア

通貚: USD 曎新時刻: 2025-10-30

䞻芁むンサむト

同瀟の財務状況は比范的非垞に健党です。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟を匷い買いず評䟡したした。株䟡のパフォヌマンスは䜎調ですが、ファンダメンタルズは堅調です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

CeriBell Incのスコア

関連情報

業界内順䜍
71 / 210
党䜓ランキング
156 / 4621
業皮
医療機噚 & 備品

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

8 人のアナリスト予想に基づく
匷力買い
珟圚の評䟡
29.667
目暙株䟡
+146.61%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

CeriBell Incの泚目ポむント

匷みリスク
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
高成長
同瀟の収益は過去3幎間にわたり着実に増加しおおり、幎平均で152.47%の成長率を瀺しおいたす。
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 65.44Mに達しおいたす。
割高
同瀟の最新のPEは-8.40で、過去3幎間の氎準ず比范しお高倀圏にありたす。
機関投資家の買い増し
最新の機関投資家の保有株数は30.96M株で、前四半期比で10.03%増加しおいたす。
PRFDXが保有
スタヌ投資家PRFDXは本銘柄を1.10K株保有しおいたす。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

CeriBell Incの䌁業情報

Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
䌁業コヌドCBLL
䌁業名CeriBell Inc
最高経営責任者「CEO」Ms. Xingjuan (Jane) Chao, Ph.D.
りェブサむトhttps://ceribell.com/
KeyAI
î™